Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

thymidylate synthase; cytotoxicity; 1,2,3-triazole; 1,3,4-oxadiazole; 5-fluoruracil; pemetrexed; docking; 3,4′-bis-guanidino; 3-amino-4′-guanidino; diphenyl ether; phenyl pyridyl ether; intramolecular hydrogen bond; cancer cell viability; HL-60; BRAF; apoptosis; thieno[2,3-d][1,2,3]triazine; acetamide; H1299; HER2; EGFR; Bcl-2 inhibitors; Indole-based analogues; benzimidazole; MTT cytotoxic assay; cell cycle analysis; DNA fragmentation; ELISA; solid/lipid nanoparticles; phenstatin; letrozole; tubulin polymerisation inhibitor; aromatase inhibitor; breast cancer; hybrid molecule; dual-targeting molecule; designed multiple ligand; NaMSA; cyclophosphamide; histopathology; testis; urinary bladder; anticancer agents; enantioselective synthesis; gastric adenocarcinoma; tryptophanol; concentration-guided dosing; model informed dosing; physiologically based pharmacokinetics; sorafenib; tyrosil-DNA-phosphodiesterase 1; adamantane; resin acid; TDP1; cytotoxic agents; apoptosis induction; HT-29 cells; MDA-MB-231 cells; mechanism prediction; STAT inhibitors; miR-21; hydrazide derivatives; nitrogen scaffolds; mitoxantrone; cardiotoxicity; inflammation; oxidative stress; age; cumulative dose; Trk; NTRK; tissue-agnostic; larotrectinib; entrectinib; Trk fusion; protein kinase inhibitors; USFDA; cancer; patent review; generic product; doxazosin; MD simulations; combretastatin A-4; cytotoxic activity; hybrid compounds; indazole; mucin; MUC1; MUC16; immunotherapy; cancer vaccine; CAR (chimeric antigen receptor); ADC (antibody-drug conjugate); thiourea; interleukin-6; trypan blue assay; chalcones; exportin-1; covalent binding; CovDock; anticancer activity; xanthone; in vitro; in vivo; isolation; synthesis; heterocyclic compound; benzenesulfonamides; imidazoles; alkylated; colony formation; tumor spheroids; HDAC inhibitors; chalcone; dual inhibitors; carvedilol; kidney; toxicity; 7-deaza-4′-thioadenosine derivatives; multi-kinase inhibitor; anticancer; nucleoside; Imiquimod; drug efflux; multidrug resistance; Toll-Like Receptor; n/a